160 related articles for article (PubMed ID: 2209248)
41. Treatment of multiple myeloma.
San Miguel JF; Bladé Creixenti J; García-Sanz R
Haematologica; 1999 Jan; 84(1):36-58. PubMed ID: 10091392
[TBL] [Abstract][Full Text] [Related]
42. Complete remission of multiple myeloma after autoimmune hemolytic anemia: possible association with interferon-alpha.
Gesundheit B; Zelig O; Shapira MY; Ackerstein A; Avgil M; Or R
Am J Hematol; 2007 Jun; 82(6):489-92. PubMed ID: 17236186
[TBL] [Abstract][Full Text] [Related]
43. Combination therapy of M2-protocol and interferon-alpha as remission induction in refractory multiple myeloma.
Shimamoto Y; Matsuzaki M; Ono K; Sano M; Yamaguchi M
Haematologia (Budap); 1991; 24(1):9-11. PubMed ID: 1813363
[TBL] [Abstract][Full Text] [Related]
44. [Multiple myeloma].
Almazov VA; Afanasév BV; Podoltseva ZI
Klin Med (Mosk); 1993; 71(2):5-10. PubMed ID: 8046926
[No Abstract] [Full Text] [Related]
45. Prolonged survival after intensive therapy and purged ABMT in patients with multiple myeloma.
Reece DE; Brockington DA; Phillips GL; Barnett MJ; Klingemann HG; Nantel SH; Sutherland HJ; Shepherd JD
Bone Marrow Transplant; 2000 Sep; 26(6):621-6. PubMed ID: 11041567
[TBL] [Abstract][Full Text] [Related]
46. [Therapy of multiple myeloma: present and future].
Tura S
G Clin Med; 1986 Dec; 67(5-6):261-4, 266-7. PubMed ID: 3301488
[No Abstract] [Full Text] [Related]
47. Intensive therapy for myeloma.
McElwain TJ; Meldrum M; Gore ME; Millar BC; Malpas JS
Pathol Biol (Paris); 1990 Oct; 38(8):830. PubMed ID: 2274375
[No Abstract] [Full Text] [Related]
48. The management of myelomatosis.
Galton DA; Brito-Babapulle F
Eur J Haematol; 1987 Nov; 39(5):385-98. PubMed ID: 2446915
[No Abstract] [Full Text] [Related]
49. [Multiple myeloma. Biological, prognostic, and therapeutic aspects].
Corrado C; Pavlovsky S
Sangre (Barc); 1990 Aug; 35(4):289-97. PubMed ID: 1703328
[No Abstract] [Full Text] [Related]
50. [Progress in the treatment of multiple myeloma].
Wada M; Mizoguchi H
Gan To Kagaku Ryoho; 1997 Jul; 24(9):1079-88. PubMed ID: 9239160
[TBL] [Abstract][Full Text] [Related]
51. [clinical study and physiopathology of multiple myeloma].
Kuramoto A
Nihon Naika Gakkai Zasshi; 1992 Sep; 81(9):1335-47. PubMed ID: 1453054
[No Abstract] [Full Text] [Related]
52. Evolution of multiple myeloma treatment from melphalan monotherapy to bone marrow transplantation.
Hájek R; Adam Z; Vásová I; Král Z
Acta Med Austriaca; 1996; 23(3):85-91. PubMed ID: 8798281
[TBL] [Abstract][Full Text] [Related]
53. Thalidomide maintenance in multiple myeloma: certainties and controversies.
Cavo M; Pantani L; Tacchetti P; Pallotti MC; Brioli A; Petrucci A; Zamagni E; Tosi P
J Clin Oncol; 2009 Nov; 27(32):e186-7; author reply e188. PubMed ID: 19770366
[No Abstract] [Full Text] [Related]
54. Maintenance treatment with recombinant alpha interferon after autologous bone marrow transplantation for aggressive myeloma in first remission after conventional induction chemotherapy.
Attal M; Huguet F; Schlaifer D; Payen C; Lassoued S; Laroche M; Rossi JF; Fournie B; Mazieres B; Pris J
Bone Marrow Transplant; 1991 Aug; 8(2):125-8. PubMed ID: 1933053
[TBL] [Abstract][Full Text] [Related]
55. Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy.
Mandelli F; Avvisati G; Amadori S; Boccadoro M; Gernone A; Lauta VM; Marmont F; Petrucci MT; Tribalto M; Vegna ML
N Engl J Med; 1990 May; 322(20):1430-4. PubMed ID: 2184356
[TBL] [Abstract][Full Text] [Related]
56. [Alpha-interferon in present-day treatment of myeloma].
Demina EA; Votiakova OM
Gematol Transfuziol; 1996; 41(2):32-6. PubMed ID: 8754159
[No Abstract] [Full Text] [Related]
57. [Maintenance treatment with interferon-alfa in multiple myeloma after autotransplantation of peripheral blood progenitor cells. Spanish Register of Transplantation in Myeloma].
García Laraña J; Díaz Mediavilla J; Martínez R; Lahuerta JJ; Alegre A; Odriozola J; Sureda A; San Miguel J; De la Rubia J; Escudero A; Conde E; Bladé J; Cabrera R; Gastearena J; Besalduch J; Vidal MJ; Hernández F; Rifon J; Leon A; Mataix R; Parody R; Moraleda JM; Solano C; de Pablos JM; Sánchez JJ
Sangre (Barc); 1997 Apr; 42 Suppl 1():38-41. PubMed ID: 9381300
[No Abstract] [Full Text] [Related]
58. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.
Kumar L; Raju GM; Ganessan K; Shawgi S; Menon H; Wadhwa J; Sharma A; Singh R; Kochupillai V
Natl Med J India; 2003; 16(1):16-21. PubMed ID: 12715951
[TBL] [Abstract][Full Text] [Related]
59. [Current therapy concepts in patients with multiple myeloma].
Heyll A; Schneider P; Bauser U; Kobbe G; Hünerlitürkoglu A; Aul C; Haas R
Dtsch Med Wochenschr; 2000 Oct; 125(40):1201-9. PubMed ID: 11075253
[No Abstract] [Full Text] [Related]
60. [Efficacy of intralesional interferon in the reduction of extramedullary masses in a case of lymphoblastic leukosis].
Alba P; Franco R; Caballero D; León A
Sangre (Barc); 1991 Jun; 36(3):250. PubMed ID: 1948548
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
